T_H17 cells are increased in the peripheral blood of patients with SAPHO syndrome

References

• Nguyen, M. T., A. Borchers, C. Selmi, et al. 2012. The SAPHO syndrome. Semin. Arthritis Rheum. 42: 254–265
   PubMed Web of Science ®Google Scholar
• Van Doornum, S., D. Barraclough, G. McColl, and I. Wicks. 2000. SAPHO: rare or just not recognized? Semin. Arthritis Rheum. 30: 70–77
   PubMed Web of Science ®Google Scholar
• Colina, M., C. Pizzirani, M. Khodeir, et al. 2010. Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: successful treatment with anakinra. Rheumatology (Oxford) 49: 1416–1418
   PubMed Web of Science ®Google Scholar
• Braun-Falco, M., and T. Ruzicka. 2011. Skin manifestations in autoinflammatory syndromes. J. Dtsch. Dermatol. Ges. 9: 232–246
   PubMed Web of Science ®Google Scholar
• Ferguson, P. J., and M. Sandu. 2012. Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr. Rheumatol. Rep. 14: 130–141
   PubMed Web of Science ®Google Scholar
• Colina, M., M. Govoni, C. Orzincolo, and F. Trotta. 2009. Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects. Arthritis Rheum. 61: 813–821
   PubMed Web of Science ®Google Scholar
• Chiricozzi, A., S. Zhang, A. Dattola, et al. 2012. Role of Th17 in the pathogenesis of cutaneous inflammatory diseases. J. Biol. Regul. Homeost. Agents 26: 313–318
   PubMed Web of Science ®Google Scholar
• Jin, D., L. Zhang, J. Zheng, and Y. Zhao. 2008. The inflammatory Th 17 subset in immunity against self and non-self antigens. Autoimmunity 41: 154–162
   PubMed Web of Science ®Google Scholar
• Leipe, J., M. Grunke, C. Dechant, et al. 2010. Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum. 62: 2876–2885
   PubMed Web of Science ®Google Scholar
• Szalay, B., G. Meszaros, A. Cseh, et al. 2012. Adaptive immunity in ankylosing spondylitis: phenotype and functional alterations of T-cells before and during infliximab therapy. Clin. Dev. Immunol. 2012: 808724 . doi: 10.1155/2012/808724
   PubMedGoogle Scholar
• Zhang, L., Y. G. Li, Y. H. Li, et al. 2012. Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. PLoS One 7: e31000
   PubMed Web of Science ®Google Scholar
• Chao, C. C., S. J. Chen, I. E. Adamopoulos, et al. 2011. Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis. Autoimmunity 44: 243–252
   PubMed Web of Science ®Google Scholar
• Zhang, L., X. Q. Yang, J. Cheng, et al. 2010. Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity. Clin. Immunol. 135: 108–117
   PubMed Web of Science ®Google Scholar
• Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8: 942–949
   PubMed Web of Science ®Google Scholar
• Zielinski, C. E., F. Mele, D. Aschenbrenner, et al. 2012. Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 484: 514–518
   PubMed Web of Science ®Google Scholar
• Lasiglie, D., E. Traggiai, S. Federici, et al. 2011. Role of IL-1 beta in the development of human T(H)17 cells: lesson from NLPR3 mutated patients. PLoS One 6: e20014
   Web of Science ®Google Scholar
• Ovadia, A., A. Livneh, O. Feld, et al. 2013. T helper 17 polarization in familial Mediterranean fever. Genes Immun. 14: 212–216
   PubMed Web of Science ®Google Scholar
• Benhamou, C. L., A. M. Chamot, and M. F. Kahn. 1988. Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies? Clin. Exp. Rheumatol. 6: 109–112
   PubMed Web of Science ®Google Scholar
• Aerts, N. E., K. J. De Knop, J. Leysen, et al. 2010. Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression. Rheumatology (Oxford) 49: 2264–2272
   PubMed Web of Science ®Google Scholar
• Grosjean, C., M. Hurtado-Nedelec, P. Nicaise-Roland, et al. 2010. Prevalence of autoantibodies in SAPHO syndrome: a single-center study of 90 patients. J. Rheumatol. 37: 639–643
   PubMed Web of Science ®Google Scholar
• Hayem, G., A. Bouchaud-Chabot, K. Benali, et al. 1999. SAPHO syndrome: a long-term follow-up study of 120 cases. Semin. Arthritis Rheum. 29: 159–171
   PubMed Web of Science ®Google Scholar
• Sonozaki, H., H. Mitsui, Y. Miyanaga, et al. 1981. Clinical features of 53 cases with pustulotic arthro-osteitis. Ann. Rheum. Dis. 40: 547–553
   PubMed Web of Science ®Google Scholar
• Przepiera-Bedzak, H., K. Fischer, and M. Brzosko. 2013. Serum levels of angiogenic cytokines in psoriatic arthritis and SAPHO syndrome. Polskie Archiwum Medycyny Wewnetrznej 123: 297–302
   PubMed Web of Science ®Google Scholar
• Przepiera-Bedzak, H., I. Brzosko, K. Fischer, and M. Brzosko. 2012. Abstracts of the 3rd World Psoriasis & Psoriatic Arthritis Conference 2012: “Psoriasis–a global health challenge”: Stockholm, Sweden, June 27–July 1, 2012. Dermatol. Ther. 2: S50
   Google Scholar
• Wendling, D., C. Prati, and F. Aubin. 2012. Anakinra treatment of SAPHO syndrome: Short-term results of an open study. Ann. Rheum. Dis. 71: 1098–1100
   PubMed Web of Science ®Google Scholar
• Santarlasci, V., L. Cosmi, L. Maggi, et al. 2013. IL-1 and T helper immune responses. Front Immunol. 4: 182 . doi: 10.3389/fimmu.2013.00182
   PubMed Web of Science ®Google Scholar
• Omoyinmi, E., R. Hamaoui, A. Pesenacker, et al. 2012. Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis. Rheumatology (Oxford) 51: 1881–1886
   PubMed Web of Science ®Google Scholar
• Koenders, M. I., I. Devesa, R. J. Marijnissen, et al. 2008. Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice. Arthritis Rheum. 58: 3461–3470
   PubMed Web of Science ®Google Scholar
• Shepherd, J., M. C. Little, and M. J. Nicklin. 2004. Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist. J. Invest. Dermatol. 122: 665–669
   PubMed Web of Science ®Google Scholar
• Orru, V., M. Steri, G. Sole, et al. 2013. Genetic variants regulating immune cell levels in health and disease. Cell 155: 242–256
   PubMed Web of Science ®Google Scholar
• Griffin, G. K., G. Newton, M. L. Tarrio, et al. 2012. IL-17 and TNF-alpha sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation. J. Immunol. 188: 6287–6299
   PubMed Web of Science ®Google Scholar
• Hurtado-Nedelec, M., S. Chollet-Martin, P. Nicaise-Roland, et al. 2008. Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatology (Oxford) 47: 1160–1167
   PubMed Web of Science ®Google Scholar
• Pelletier, M., L. Maggi, A. Micheletti, et al. 2010. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115: 335–343
   PubMed Web of Science ®Google Scholar
• Alghasham, A., and Z. Rasheed. 2014. Therapeutic targets for rheumatoid arthritis: progress promises. Autoimmunity 47: 77–94
   Google Scholar